MariMed Inc. (MRMD)
OTCMKTS · Delayed Price · Currency is USD
0.1376
+0.0141 (11.42%)
Aug 28, 2025, 3:59 PM EDT
MariMed Revenue
MariMed had revenue of $39.61M in the quarter ending June 30, 2025, a decrease of -2.05%. This brings the company's revenue in the last twelve months to $157.16M, up 0.70% year-over-year. In the year 2024, MariMed had annual revenue of $157.96M with 6.30% growth.
Revenue (ttm)
157.16M
Revenue Growth
+0.70%
P/S Ratio
0.31
Revenue / Employee
203.05K
Employees
832
Market Cap
48.49M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 157.96M | 9.37M | 6.30% |
| Dec 31, 2023 | 148.60M | 14.59M | 10.89% |
| Dec 31, 2022 | 134.01M | 12.55M | 10.33% |
| Dec 31, 2021 | 121.46M | 70.57M | 138.66% |
| Dec 31, 2020 | 50.90M | 5.29M | 11.60% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Northwest Biotherapeutics | 1.09M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.17M |
| Global Cord Blood | 196.10M |
MariMed News
- 21 days ago - MariMed signals expansion into Pennsylvania and Maine while strengthening brand presence after Q2 revenue reaches $39.6M - Seeking Alpha
- 21 days ago - MariMed Inc. (MRMD) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 21 days ago - MariMed (MRMD) Q2 EPS Jumps to Positive - The Motley Fool
- 22 days ago - MariMed Reports Second Quarter 2025 Earnings - GlobeNewsWire
- 23 days ago - MariMed Q2 2025 Earnings Preview - Seeking Alpha
- 4 weeks ago - MariMed's Products to Enter Pennsylvania Market Through a Management Services and Licensing Agreement with TILT Holdings - GlobeNewsWire
- 4 weeks ago - MariMed's Products to Enter Pennsylvania Market Through a Management Services and Licensing Agreement with TILT Holdings - Benzinga
- 6 weeks ago - CORRECTION -- MariMed Expands Access to Top-Selling Betty's Eddies Brand in Maine - GlobeNewsWire